May 11 (Reuters) - Transition Therapeutics Inc TTH.TO
* Q3 loss per share $0.11
* Existing cash resources should enable co to execute
business plan and meet projected cash requirements beyond next
12 months
Source text for Eikon: ID:nCNWf2chfa
Further company coverage: TTH.TO
(Bengaluru Newsroom: +1-646-223-8780)